AT
Healthcare & Life Sciences
Aviceda Therapeutics
United Statesavicedarx.com
Aviceda Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Aviceda Therapeutics
Aviceda Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Aviceda Therapeutics develops novel glyco-immune checkpoint therapeutics aimed at treating immune-mediated diseases, with a focus on macular degeneration to prevent blindness.
Explore Aviceda Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.